Completed PHASE4 INTERVENTIONAL 1-arm NCT03708198

Pharmacokinetics of Single-Dose Liposomal Bupivacaine in Surgeon Performed Intercostal Nerve Blocks

Sponsor: University of Virginia

Conditions Thoracic

Updated 7 times since 2018 Last updated: May 19, 2022 Started: Jun 11, 2018 Primary completion: Oct 11, 2019 Completion: Aug 11, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Thoracic and is currently completed. University of Virginia leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jun 2022 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Nov 2020 — Dec 2020 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Recruiting PHASE4

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States